Older Americans will soon have Medicare access to GLP-1s for weight loss for the first time. Here’s what they need to know.
Starting July 1, Medicare will cover GLP-1 weight-loss drugs for qualifying beneficiaries at $50 monthly. Users should be aware of potential side effects and muscle loss that can occur with these medications.
Read full story →Why agriculture’s biggest challenges are no longer cyclical
Agriculture now faces permanent structural challenges from climate risks, shifting trade dynamics, ESG requirements, and changing consumer expectations rather than cyclical difficulties. These transformations are fundamentally altering how the sector operates across production, trade relationships, and regulatory compliance.
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits
Johnson & Johnson agreed to pay $5.5 billion to settle tens of thousands of lawsuits claiming its talc products caused ovarian cancer. The settlement resolves litigation that has pursued the company for years regarding baby powder and other talc-based products.
Peregrine Capital: AI conviction intact after volatile first half marked by war and oil shock
An oil price spike triggered by war in March caused significant market volatility that fully recovered by April. Peregrine Capital maintains confidence in artificial intelligence investments long-term despite investor concerns about near-term expenses of building AI infrastructure.